News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Helsinn and Angelini Pharma Extend Partnership to Market AULIN® and MESULID® in Bulgaria, Czech Republic, Hungary, Poland, Romania, and Slovak Republic
Tuesday, May 28, 2024Helsinn Group a prominent pharmaceutical company specializing in supportive care oncology and
Tyligand Bioscience Initiates Phase 1/2 Clinical Trial for TSN1611, a Selective Oral KRAS G12D Inhibitor, with First Patient Dosed
Monday, May 27, 2024Tyligand Bioscience a prominent biotechnology company focused on developing cuttingedge cancer therapies has reached a significant milestone with the initiation of the Phase trial of TSN
Sarah Cannon Research Institute Expands into East Tennessee through Partnership with Tennessee Cancer Specialists
Friday, May 24, 2024The Sarah Cannon Research Institute a leader in oncology research and communitybased clinical trials has announced a collaboration with Tennessee Cancer Specialists an independent oncology
Abdera Therapeutics Receives FDA Clearance for ABD-147 IND Application
Friday, May 24, 2024Abdera Therapeutics Inc a biopharmaceutical company specializing in precision radiopharmaceuticals for cancer treatment has received clearance from the US Food and Drug Administration for its Investigational New Drug application regarding ABD This ma...
DelsiTech Reveals Significant Licensing Agreement for Innovative Drug Delivery Solution
Friday, May 24, 2024DelSiTech Ltd a company specializing in clinicalstage drug delivery and development has just unveiled a significant milestone Theyve inked a Licensing Agreement with a prominent global pharmaceutical entity
Oxford Nanopore Technologies and Twist Bioscience Partner to Introduce Beta Program for Advancing Personalized Medicine via Pharmacogenomics
Thursday, May 23, 2024Today Oxford Nanopore Technologies announced the launch of a new Pharmacogenomics Beta Program aimed at advancing personalized medicine This program combines Twist Biosciences
Swixx Biopharma Expands into Latin America Through Acquisition and Merger with Biopas
Thursday, May 23, 2024Swixx BioPharma AG a global platform committed to improving access to innovative medicines worldwide has announced its strategic expansion into Latin America The company has finalized
Molecure Granted Approval to Conduct Phase II Clinical Trial for OATD-01 Targeting Pulmonary Sarcoidosis in Specific European Union and Norwegian Regions
Wednesday, May 22, 2024Molecure SA has recently obtained regulatory approvals from several European countries including
Medigene and BioNTech Extend Their Global Research and Collaboration Agreement Beyond the Initially Announced Term
Wednesday, May 22, 2024Medigene AG and BioNTech SE have announced the extension of their collaboration beyond the initial threeyear term outlined in February This extension reflects their commitment to advancing T cell
Qurient Therapeutics and the National Cancer Institute Partner for Phase 1/2 Clinical Trial of Q901 Combined with TROP2-ADC
Wednesday, May 22, 2024Qurient Co Ltd a biotechnology company based in Korea has established a Cooperative Research and Development Agreement with the US National Cancer Institute a part of the National Institutes of Health
